Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)

Clinical trial NCT03100045 · COMPLETED

Trial details

NCT number: NCT03100045
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HPV-Related Anal Intraepithelial Neoplasia AIN2/3 Artesunate Alternative Treatment Anal Dysplasia Precancerous Conditions Human Papilloma Virus

Start date: 2017-04-20
Primary completion: 2021-10-06
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.